We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
Notice for omaveloxolone (Biogen Australia Pty Ltd)
Active ingredients
omaveloxolone
Sponsor
Date of review outcome
Lapse date
Type
Orphan Drug
Dosage form(s)
Capsules (Hard)
Indication
Treatment of Friedrich’s ataxia in adults and adolescents aged 16 years and older.
Therapeutic area
Neurology